Biocatalytic Cleavage of Alkenes with O<sub>2</sub>and<i>Trametes hirsuta</i>G FCC 047
作者:Miguel Lara、Francesco G. Mutti、Silvia M. Glueck、Wolfgang Kroutil
DOI:10.1002/ejoc.200800261
日期:2008.7
Alkenes possessing a C=C double bond adjacent to an aromatic ring were cleaved to yield the corresponding carbonyl compounds by use of molecular oxygen as the sole oxidant and a cell-free extract of the wood-degrading fungus Trametes hirsuta FCC047 as catalyst. The oxygen pressure required was optimized. Special adapted equipment allowed 96 reactions to be performed in parallel under controlled oxygen
This invention concerns HIV replication inhibitors of formula
the N-oxides, the pharmaceutically acceptable addition salts, the quaternary amines and the stereochemically isomeric forms thereof; their use as a medicine, their processes for preparation and pharmaceutical compositions comprising them.
The invention relates to organic electroluminescent devices comprising organic compounds with a double or triple bond, to which at least one aromatic ring is bonded, as emitter compounds. The invention also relates to possible uses of said devices.
SHOSTAKOVSKIJ, V. M.;VASILVITSKIJ, A. E.;MUSAEV, A. U.;NEFEDOV, O. M., AZOTSODERZH. GETEROTSIKLY, NOVOSIBIRSK,(1987) 88
作者:SHOSTAKOVSKIJ, V. M.、VASILVITSKIJ, A. E.、MUSAEV, A. U.、NEFEDOV, O. M.
DOI:——
日期:——
Pyrimidine derivatives for the prevention of hiv infection
申请人:Heeres Jan
公开号:US20070021449A1
公开(公告)日:2007-01-25
This invention concerns the use of a compound for the manufacture of a medicament for the prevention of HIV infection via sexual intercourse and related intimate contact between partners, wherein the compound is a compound of formula (I) a N-oxide, a pharmaceutically acceptable addition salt, a quaternary amine and a stereochemically isomeric form thereof, wherein the ring containing -a
1
=a
2
-a
3
=a
4
- and -b
1
=b
2
-b
3
=b
4
- represents phenyl, pyridyl, pyrimidinyl, pirazinyl, pyridazinyl; and pharmaceutical compositions comprising them.